PHILIP A. HART, Michigan MARLOW W. COOK, Kentucky ROMAN L. HRUSKA, Nebraska CHARLES MCC. MATHIAS, JR., Maryland MATHEA FALCO, Staff Director and Chief Counsel CONTENTS ALPHABETICAL LIST OF WITNESSES Baumgold, Julie, contributing editor, New York Magazine_-_. Daroff, Les, panel of former methaqualone abusers (accompanied by Pat, Max R. Poynton, Paul Keel, and Gary Doby) Doby, Gary, panel of former methaqualone abusers (accompanied by Eckman, John W., president and chief executive officer, William H. Rorer, Inc., Fort Washington, Pa. (accompanied by Dr. Nelson H. Reavey- French, Jr., Glendon E., executive vice president and chief administrative officer, Arnar-Stone Laboratories, Inc. (accompanied by Richard D. Gardner, Dr. Elmer A., Director, Division of Neuropharmacological Drug Gardner, Sherwin, Acting Commissioner of Food and Drugs, Food and Drug Administration (accompanied by John Jennings, Elmer Gardner, Peter Barton Hutt, and Gerald F. Meyer), Washington, D.C..- Gay, George R., M.D., F.A.C.A., director of clinical activities, Haight- Ashbury Free Medical Clinic, San Francisco, Calif.. Gilbert, Gerald E., counsel, Hogan and Hartson, for Parke, Davis & Co., Detroit, Mich. (accompanied Dr. Leslie M. Lueck)_. Hutt, Peter Barton, General Counsel, Food and Drug Division, Food and Keel, Paul, panel of former methaqualone abusers (accompanied Les Daroff, Pat, Max R. Poynton, and Gary Doby). Kunnes, Dr. Richard, psychiatrist, Medical School faculty, University of Michigan, and director, University of Michigan-Washtenaw County Community Mental Health Center's outpatient program, Ann Arbor, Lueck, Dr. Leslie M., vice president, quality control and government regu- lations, Parke, Davis & Co., Detroit, Mich. (accompanied by Charles Lents and Gerald E. Gilbert) _ Manthei, Richard D., secretary and counsel, Arnar-Stone Laboratories, Inc., Mount Prospect, Ill. (accompanied Glendon E. French, Jr.)----- Meyer, Gerald F., Director, Office of Legislative Services, Food and Drug Inaba, Darryl S., Pharm D., chief pharmaceutical services drug detoxifi- cation, rehabilitation and aftercare project of the Haight-Ashbury Free Medical Clinic, San Francisco, Calif. (accompanied Dr. George Gay)... 188b Inciardi, Dr James A., associate professor, Division of Addiction Sciences, Department of Psychiatry, University of Miami School of Medicine, Miami, Fla.; associate director of research, metropolitan Dade County (Fla.) comprehensive drug program, and senior associate, resource Planning Corp., Washington, D.C., Miami, Fla. -- Jennings, Dr. John, Associate Commissioner for Medical Affairs, Food and McMurray, Raymond D., counsel for Cooper Laboratories, Inc., Bedford Hills, N. Y. (accompanied Dr. Robert C. O'Neill) – O'Neill, Dr. Robert C., executive vice president, Cooper Laboratories, Inc., Pat, panel of former methaqualone abusers (accompanied Les Daroff, Poynton, Max R., panel of former methaqualone abusers (accompanied Pat, Quay, Thomas E., general counsel, William H. Rorer, Inc., Fort Washing- Reavey-Cantwell, Dr. Nelson H., associate professor of medicine, Jefferson ALPHABETICAL LIST OF ORGANIZATIONS REPRESENTED Arnar-Stone Laboratories, Inc., Mount Prospect, Ill Food and Drug Administration, Department of Health, Education and Haight-Ashbury Free Medical Clinic, San Francisco, Calif. New York Magazine, New York, N. Y. Panel of former Methaqualone Abusers, Washington, D.C. Parke, Davis & Company, Detroit, Mich. Rorer, William H., Inc., Fort Washington, Pa.... University of Miami School of Medicine, Division of Addiction Sciences, CHRONOLOGICAL LIST OF WITNESSES MARCH 28, 1973 Daroff, Les, Pat, Max R. Poynton, Paul Keel, and Gary Doby, panel of former methaqualone abusers__ Schnoll, Dr. Sidney, Department of Pharmacology, Jefferson Medical Col lege, Thomas Jefferson University Philadelphia, Pa. Inciardi, Dr. James, associate professor, Division of Addiction Sciences, Baumgold, Julie, contributing editor, New York Magazine, New York, N. Y.. MARCH 29, 1973 Gardner, Sherwin, acting commissioner of food and drugs, the Food and Gay, Dr. George, F.A.C.A., director of clinical activities, Haight-Ashbury Lueck, Dr. Leslie, vice president, quality control and government regulations, Parke, Davis & Company, Detroit, Mich. (accompanied by Charles Lents and Gerald E. Gilbert). O'Neill, Dr. Robert C., executive Vice president, Cooper Laboratories, Inc., Page 254 254 77 77 264 264 89 301 254 150 188b 89 115 77 233 264 105 138 77 89 105 115 138 150 188b 233 254 APRIL 6, 1973 Eckman, John W., president and chief executive officer, William H. Rorer, French, Jr., Glendon E., executive vice president and chief administrative officer, Arnar-Stone Laboratories, Inc., Mount Prospect, Ill. (accompanied by Richard D. Manthei)....... LIST OF EXHIBITS 1. Text of Senate Resolution 56, section 12, 93d Congress, first session, dated February 27, 1973, authorizing expenditures for the subcommittee to investigate juvenile delinquency 2. Text of Public Law 91-513, 91st Congress, H.R. 18583, dated October 27, 1970, the "Comprehensive Drug Abuse Prevention and Con trol Act of 1970". 3. Text of S. 1252, the "Methaqualone Control Act of 1973,' dated March 15, 1973, 93d Congress, 1st session, introduced by Hon. Birch Bayh... 4. Statement submitted by Hon. Roman L. Hruska, March 28, 1973, U.S. Senator from the State of Nebraska_ 5. Photograph depicting "Captain Quaalude" T-shirt, submitted by Dr. Sidney Schnoll.. 6. Article, “Down at the Juice Bars," by Julie Baumgold, New York 7. Article, "The King of the Juice Bars," by Julie Baumgold, New York 8. Methaqualone: "Summary of Literature Reports of Misuse,' 9. Letter from FDA requesting NIMH advice, February 14, 1973.. 11. Paper, "Cheap Thrills On Steep Hills: The Abuse of Methaqualone in Perspective," by Dr. Darryl S. Inaba, Dr. George R. Gay, Dr. John A. Newmeyer, and Dr. Craig Whitehead, 1973. 12. Letter to Hon. Birch Bayh, U.S. Senator, from Dr. Darryl S. Inaba, Chief, Pharmaceutical Services Drug Detoxification, Rehabilitation and After Care Project of the Haight-Ashbury Free Medical Clinic, enclosure, entitled, "An Epidemiological Analysis of the Fluctuation of Drug Dependence in Japan," by Dr. Masaaki Kato, The International Journal of the Addictions, 4(4), pp. 591-621, December 1969____ 13. Letters submitted by Dr. Leslie M. Lueck, Parke, Davis & Co., supporting additional control for methaqualone, submitted March 29, 1973... 14. Report, "Telephone Dictations to M. Nye, Re: Methaqualone/ Maryland Schedule IV," submitted by John Eckman, William H. Rorer, Inc., April 16, 1973. 15. Letter to Mary Jolly, editorial director and chief clerk of the subcommittee, from C. H. Tregoe, chief, Division of Drug Control, State of Maryland, November 3, 1972... 16. Package insert "Quaalude " submitted by John Eckman, William H. Rorer, Inc., April 16, 1973.. 17. Letter to Mary Jolly, editorial director and chief clerk of the subcommittee from Thomas E. Quay, general counsel, William H. Rorer, Inc., dated April 16, 1973... 18. Ad, entitled, "For graduate student John R., lying down to sleep was 300 Page 264 301 6 11 72 74 99 123 130 152 178 182 191 202 242 271 272 288 295 296 19. Ad, entitled, "A good morning after a sleep-through night," Quaalude300R (methaqualone), William H. Rorer, Inc., Fort Washington, Pa., Psychiatric News, August 18, 1971, pages 8-9 20. Letter to C. H. Tregoe, chief, Division of Drug Control, State of Maryland, from John F. Zaroslinski, Ph.D., vice president, research and development, Arnar-Stone Laboratories, Inc., October 24, 1972. 21. Photographs depicting counterfeit and authentic Árnar-Stone methaqualone, submitted by Glendon E. French, Jr., Arnar-Stone Laboratories, Inc., April 6, 1973___ Page 299 300 305 |
0 Atsauksmes Atsauksmes netiek pārbaudītas, taču Google meklē viltus saturu un noņem to, ja tāds tiek identificēts. Rakstīt atsauksmi |